1. Ailments in Covid-19 Trials Raise Questions About Vaccine Method  Bloomberg
  2. Better Coronavirus Stock: AstraZeneca or Johnson & Johnson  The Motley Fool
  3. View Full Coverage on Google News

Bloomberg - Are you a robot?

These two pharma heavyweights are among the many players racing to get a COVID-19 vaccine approved.These two pharma heavyweights are among the many players racing to get a COVID-19 vaccine approved.

Better Coronavirus Stock: AstraZeneca or Johnson & Johnson | The Motley Fool